Press ESC to close

Rare Blood Cancer

Rare Blood Cancer

Rare blood cancers are a group of blood cancers that are less common compared to more well-known types like leukemia, lymphoma, and myeloma. These rare blood cancers can affect the production and function of blood cells, leading to various symptoms and complications.

Rare blood cancers include:

  • Myelofibrosis: A rare blood cancer that causes scarring of the bone marrow, which can develop into acute leukemia in some people.
  • Chronic myelomonocytic leukemia (CMML): A rare form of blood cancer that affects the white blood cells called granulocytes and monocytes.
  • Polycythemia vera (PV): A rare blood cancer that causes an increase in red blood cells, which can also lead to an excess of white blood cells and platelets.
  • Essential thrombocythemia (ET): A rare blood cancer that causes the bone marrow to produce too many platelets, leading to bleeding or clotting problems.
  • Paroxysmal nocturnal hemoglobinuria (PNH): A rare blood disorder characterized by the production of abnormal red blood cells that are prone to destruction.
  • Langerhans cell histiocytosis: A rare condition that causes an increase in a type of white blood cells called Langerhans cells or histocytes, primarily affecting children but also occurring in adults.
  • Waldenstrom macroglobulinemia: A rare and slow-growing cancer that primarily affects older adults, mainly occurring in the bone marrow but also involving the spleen and lymph nodes.
  • Myelodysplastic syndromes (MDS): A group of blood cancers characterized by the production of abnormal blood cells, which can lead to anemia, infection, and bleeding.

These rare blood cancers are often diagnosed through a combination of physical examinations, laboratory tests, and imaging procedures. Treatment options vary depending on the specific type and severity of the condition, but may include chemotherapy, targeted therapies, and stem cell transplants.


New York Cancer & Blood Specialists (NYCBS) is a network of community oncology treatment centers that provides comprehensive cancer care to patients across Long Island and New York City. The organization is committed to delivering state-of-the-art medical technology and world-class cancer care to its patients, with a focus on patient-centered and affordable care.

Key Features

  • Locations: NYCBS has multiple locations across Long Island and New York City, including offices in Astoria, Babylon, Bay Shore, Bethpage, Brooklyn, Central Park, Downtown Brooklyn, East New York, Eastchester, Elmhurst, Forest Hills, Fresh Meadows, Jackson Heights, Lake Success, Middletown, New Hyde Park, Newburgh, Patchogue, Port Jefferson Station, Riverhead, Ronkonkoma, Smithtown, Southampton, Staten Island, and Upper East Side.
  • Services: The organization offers a range of services, including medical and radiation oncology, lymphedema therapy, medical massage, nutrition, occupational and physical therapy, psychology, social work, survivorship care planning, individualized care coordination and one-on-one instruction by a qualified nurse for each patient.
  • Patient Testimonials: Patients have praised NYCBS for its exceptional care, citing the dedication of doctors, nurses, and staff members. For example, Beverly MacD expressed gratitude for the care she received, particularly from Dr. Chu and the office staff.
  • Partnership with Mount Sinai: NYCBS is part of the Mount Sinai Health System, ensuring that patients have access to advanced treatments and research opportunities.
  • Phone Numbers and Directions: Patients can contact NYCBS at (855) 528-7322 or visit their website for directions to each location.

Mission Cancer + Blood

Mission Cancer + Blood is a physician-owned oncology practice in Iowa that provides comprehensive cancer and blood care services. Here are some key points about the organization:

Community-Based Healthcare

Mission Cancer + Blood is a community-based healthcare team of cancer and blood specialists dedicated to providing the best possible care and treatment options for patients.


The practice is proud to partner with the John Stoddard Cancer Center at Unity Point, the Mercy One Cancer Center, and The Iowa Clinic, ensuring coordinated cancer care and the delivery of high-quality treatment options.

Certifications and Accreditations

  • Mission Cancer + Blood is a Quality Oncology Practice Initiative (QOPI) Certified practice through the American Society of Clinical Oncology, demonstrating its commitment to quality care.
  • The practice has also received the NCODA Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation for three years, highlighting its commitment to providing high-quality care.


The organization is led by CEO Phil Stover, CFO Katie Beecher, and Physician Liaison Kristen Buenzow.

Research and Clinical Trials

Mission Cancer + Blood is committed to providing evidence-based treatments, tumor boards, genetic counseling, and clinical trials, matching or exceeding the care available in any community oncology practice in the country.

Awards and Recognition

Tara Graff, a physician at Mission Cancer + Blood, was named The Leukemia & Lymphoma Society Heartland Visionary for her dedication to providing cutting-edge care and her passion for research.


  • The practice is located at 100 E. Grand Ave., Ste. 200, Des Moines, IA 50309.

Contact Information

  • Phone: (515) 282-2921
  • Fax: (515) 282-1035
  • Email: Kristen Buenzow.

Overall, Mission Cancer + Blood is a well-established and respected oncology practice in Iowa, committed to delivering high-quality care and treatment options to its patients.


New York Cancer & Blood Specialists is a comprehensive cancer care network that provides patients with advanced treatments and personalized care in their own communities.


1: What is RDW blood test?

A high Red Cell Distribution Width (RDW) blood test is associated with several types of cancer, including blood-related cancers, lung cancer, colon cancer, and ovarian cancer. Here are some key points related to the relationship between a high RDW and cancer:

  • Cancer Prognosis: A high RDW may signify a poorer prognosis in patients with several types of cancer, including blood-related cancers, lung cancer, and colon cancer.
  • Ovarian Cancer: In patients with ovarian cancer, a high RDW is positively correlated with the stage of the cancer, indicating that the RDW may be a potential marker for disease progression.
  • Cancer Risk: A high RDW has been linked to an increased risk of cancer in men, particularly in those with advanced cancer stages. In postmenopausal age groups, women with high RDWs have an increased risk of incident cancer.
  • Mechanisms: The exact mechanisms underlying the association between RDW and cancer are not fully understood but may involve factors such as inflammation, anemia, and nutrient deficiencies.
  • Clinical Significance: The RDW test is part of a complete blood count (CBC) and can be used to identify patients with a higher risk of cancer. However, the test is not a definitive diagnostic tool and should be used in conjunction with other diagnostic methods.

In summary, a high RDW blood test is associated with several types of cancer and may be a useful marker for disease progression and prognosis.

2: What is blood cancer called?

Blood cancer is a type of cancer that affects the blood cells, bone marrow, or lymphatic system. It is characterized by abnormal growth and development of blood cells, which can interfere with the normal functioning of the blood and bone marrow. Leukemia, lymphoma, and myeloma are the three main types of blood cancer.

3: Is blood cancer curable?

Yes, blood cancer is curable if diagnosed and treated early. The curability of blood cancer depends on various factors such as the type of cancer, stage of the disease, patient’s age and physical condition, presence of comorbidities, and the effectiveness of treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *